Artelo Biosciences, Inc.宣布与Sciencemachine建立战略合作伙伴关系，双方将重点推进脂肪酸结合蛋白5（FABP5）抑制剂的研发进程。此次合作旨在整合两家公司在生物医药领域的专业优势，加速创新疗法的开发。
通过资源共享与技术互补，Artelo Biosciences将与Sciencemachine共同探索FABP5抑制剂在肿瘤治疗等领域的应用潜力。该合作标志着Artelo Biosciences在扩大研发管线方面迈出重要一步，也为双方未来在生物制药领域的深度协作奠定基础。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.